Trevi Therapeutics files Form 144 for planned share sale

au.investing.com —

Trevi Therapeutics filed a Form 144 with the SEC on November 15, indicating a planned sale of company shares. The filing signals an intent to sell shares, often by an insider or major shareholder, and is a routine regulatory disclosure. Form 144 is a notice of proposed sale of securities, not a confirmation of the sale itself, and does not specify the seller's identity or share amount.


With a significance score of 0.9, this news ranks in the top 74% of today's 30826 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: